MML Investors Services
NAGE

MML Investors Services’s Niagen Bioscience NAGE Stock Holding History

MML Investors Services’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,550
Closed -$94K – 1659
2019
Q1 		$94K Sell
22,550
-2,650
-11% -$9.55K ﹤0.01% 1556
2018
Q4 		$86K Sell
25,200
-8,600
-25% -$29.9K ﹤0.01% 1465
2018
Q3 		$145K Buy
33,800
+13,000
+63% +$55.9K ﹤0.01% 1547
2018
Q2 		$77K Buy
20,800
+8,500
+69% +$32.3K ﹤0.01% 1333
2018
Q1 		$52K Buy
+12,300
New +$64.4K ﹤0.01% 1348

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MML Investors Services's NAGE Position: Q2 2019 in Review

MML Investors Services sold out of Niagen Bioscience (NAGE) in Q2 2019, closing a stake of 22,550 shares — an estimated $94K sold.

MML Investors Services first reported a position in NAGE in Q1 2018 and held it in 5 quarters. The position peaked at $145K in Q3 2018. 58 funds tracked by Wall St. Rank hold NAGE as of Q2 2019.

  • MML Investors Services reported no remaining Niagen Bioscience position as of Q2 2019 after selling out during the quarter.
  • MML Investors Services sold 22,550 Niagen Bioscience shares in Q2 2019, an estimated $94K.
  • MML Investors Services first reported a position in Niagen Bioscience in Q1 2018 and held it in 5 quarters.
  • MML Investors Services's Niagen Bioscience position peaked at $145K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2019.

Based on MML Investors Services's 13F filing for Q2 2019, filed 13 Aug 2019.